Instruction for use: Gastrozem

Active substance: Pirenzepine

ATX Code

A02BX03 Pirenzepine

Pharmacological group

M Cholinolytics

The nosological classification (ICD-10)

K25 Gastric ulcer

Helicobacter pylori, Pain syndrome in gastric ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, Inflammation of the gastric mucosa, Inflammation of the gastrointestinal mucosa, Benign gastric ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Aggravation gastroduodenita on the background of peptic ulcer, Exacerbation of peptic ulcer, The aggravation of gastric ulcer, The organic gastrointestinal disease, Peptic ulcer of the stomach and duodenum, Postoperative gastric ulcer, Recurrent ulcers, Symptomatic gastric ulcers, Chronic inflammatory disease of the upper gastrointestinal tract, associated with Helicobacter pylori, Helicobacter pylori eradication, Erosive and ulcerative lesions of the stomach, Erosive lesions of the stomach, The erosion of the gastric mucosa, Peptic ulcer disease, Stomach ulcer, Gastric lesion, Ulcerative lesions of the stomach, Symptomatic ulcers of the stomach and duodenum

K26 Duodenal Ulcer

Pain with duodenal ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Exacerbation of peptic ulcer, The worsening of duodenal ulcer, Peptic ulcer of the stomach and duodenum, Relapse of duodenal ulcers, Symptomatic ulcers of the stomach and duodenum, Helicobacter pylori eradication, Erosive and ulcerative lesions of the duodenum, Erosive-ulcerative lesions of duodenal ulcers associated with Helicobacter pylori, Erosive lesions of the duodenum, Duodenal ulcer, Ulcerative lesions of the duodenum]

K29 Gastritis and duodenitis

Aggravation gastroduodenita on the background of peptic ulcer, duodenitis

Structure and Composition

1 tablet contains 25 mg of pirenzepine hydrochloride; in blister 20 pcs., in a carton one blister.

pharmachologic effect

Mode of action - antiulcer.

Selectively blocks M1-cholinergic receptors, it lowers both basal and stimulated acid secretion, reduces peptic activity of gastric juice.

Indications

Gastric ulcer and duodenal ulcer, hyperacid gastritis, erosive gastritis.

Contraindications

Hypersensitivity, pregnancy (first trimester), children's age.

Side effects

Dry mouth, increased appetite, diarrhea, disturbance of accommodation.

Dosing and Administration

Inside, the food 50 (First) - 150 mg (maximum) per day for 2-3 weeks.

Storage conditions

In a dry, dark place at a temperature of 10-25 ° C.

Keep out of the reach of children.

shelf life

3 years.

Do not use beyond the expiration date printed on the package.